Cerulean Pharma

Investors feel blue as Cerulean admits defeat on cancer

Shares in Cerulean Pharma nosedived yesterday after the company agreed to sell off its anticancer assets at a bargain basement price and merge with Daré Bioscience.

Phil Taylor Mar 21, 2017 10:16am

Novartis partners with tiny microcap Cerulean as it nabs $20M

Oct 19, 2016 9:12am

Cerulean is blue as it cuts half of staffers after cancer trial failure

Aug 19, 2016 6:16am